Clinical Trials List
Protocol Number20180119
Active
2023-03-01 - 2028-05-04
Phase IV
Recruiting2
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 李佳真 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳昭銘 Division of Orthopedics
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
35 participants
